LRRK2 G2019S and I2020T mutations are not common in Alzheimer's disease and vascular dementia

被引：9

作者：

Lee, E.

Hui, S.

Ho, G.

Tan, E. K.

Chen, C. P.

机构：

[1] Singapore Gen Hosp, Dept Neurol, Singapore 169608, Singapore

[2] Singapore Gen Hosp, Natl Inst Neurosci, Singapore 169608, Singapore

[3] Singapore Gen Hosp, SingHlth, Singapore 169608, Singapore

来源：

AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS | 2006年 / 141B卷 / 05期

关键词：

PARKINSONS-DISEASE;

D O I：

10.1002/ajmg.b.30305

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

引用

页码：549 / 550

页数：2

共 10 条

[1]

Di Fonzo A, 2005, LANCET, V365, P412

[2] Common LRRK2 mutation in idiopathic Parkinson's disease [J].

Gilks, WP ;

Abou-Sleiman, PM ;

Gandhi, S ;

Jain, S ;

Singleton, A ;

Lees, AJ ;

Shaw, K ;

Bhatia, KP ;

Bonifati, V ;

Quinn, NP ;

Lynch, J ;

Healy, DG ;

Holton, JL ;

Revesz, T ;

Wood, NW .

LANCET, 2005, 365 (9457) :415-416

[3] The dardarin G2019S mutation is a common cause of Parkinson's disease but not other neurodegenerative diseases [J].

Hernandez, D ;

Ruiz, CP ;

Crawley, A ;

Malkani, R ;

Werner, J ;

Gwinn-Hardy, K ;

Dickson, D ;

DeVrieze, FW ;

Hardy, J ;

Singleton, A .

NEUROSCIENCE LETTERS, 2005, 389 (03) :137-139

[4] The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease [J].

Lu, CS ;

Simons, EJ ;

Wu-Chòu, YH ;

Di Fonzo, A ;

Chang, HC ;

Chen, RS ;

Weng, YH ;

Rohé, CF ;

Breedveld, GJ ;

Hattori, N ;

Gasser, T ;

Oostra, BA ;

Bonifati, V .

PARKINSONISM & RELATED DISORDERS, 2005, 11 (08) :521-522

[5] Analysis of LRRK2 functional domains in nondominant Parkinson disease [J].

Skipper, L ;

Shen, H ;

Chua, E ;

Bonnard, C ;

Kolatkar, P ;

Tan, LCS ;

Jamora, RD ;

Puvan, K ;

Puong, KY ;

Zhao, Y ;

Pavanni, R ;

Wong, MC ;

Yuen, Y ;

Farrer, M ;

Liu, JJ ;

Tan, EK .

NEUROLOGY, 2005, 65 (08) :1319-1321

[6] The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients [J].

Tan, EK ;

Shen, H ;

Tan, LCS ;

Farrer, A ;

Yew, K ;

Chua, E ;

Jamora, RD ;

Puvan, K ;

Puong, KY ;

Zhao, Y ;

Pavanni, R ;

Wong, MC ;

Yih, Y ;

Skipper, L ;

Liu, JJ .

NEUROSCIENCE LETTERS, 2005, 384 (03) :327-329

[7] Variability and validity of polymorphism association studies in Parkinson's disease [J].

Tan, EK ;

Khajavi, M ;

Thornby, JI ;

Nagamitsu, S ;

Jankovic, J ;

Ashizawa, T .

NEUROLOGY, 2000, 55 (04) :533-538

[8] LRRK2 mutations are not common in Alzheimer's disease [J].

Toft, M ;

Sando, SB ;

Melquist, S ;

Ross, OA ;

White, LR ;

Aasly, JO ;

Farrer, MJ .

MECHANISMS OF AGEING AND DEVELOPMENT, 2005, 126 (11) :1201-1205

[9] Analysis of the LRRK2 G2019S mutation in Alzheimer disease [J].

Zabetian, CP ;

Lauricella, CJ ;

Tsuang, DW ;

Leverenz, JB ;

Schellenberg, GD ;

Payami, H .

ARCHIVES OF NEUROLOGY, 2006, 63 (01) :156-157

[10] Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology [J].

Zimprich, A ;

Biskup, S ;

Leitner, P ;

Lichtner, P ;

Farrer, M ;

Lincoln, S ;

Kachergus, J ;

Hulihan, M ;

Uitti, RJ ;

Calne, DB ;

Stoessl, AJ ;

Pfeiffer, RF ;

Patenge, N ;

Carbajal, IC ;

Vieregge, P ;

Asmus, F ;

Müller-Myhsok, B ;

Dickson, DW ;

Meitinger, T ;

Strom, TM ;

Wszolek, ZK ;

Gasser, T .

NEURON, 2004, 44 (04) :601-607

← 1 →